Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17568 | 529 | 46.6 | 91% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1187 | 8873 | RESTENOSIS//INTRAVASCULAR BRACHYTHERAPY//TRANILAST |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLC OXLDL | Author keyword | 1 | 100% | 0% | 2 |
2 | MOL VASC CELL BIOL | Address | 1 | 100% | 0% | 2 |
3 | PATHOL AZ MIDDELHEIM | Address | 1 | 100% | 0% | 2 |
4 | RICHARD B LYNNE V CHENEY CARDIOVASC | Address | 1 | 100% | 0% | 2 |
5 | UNIT CARDIOVASC MED | Address | 1 | 15% | 2% | 8 |
6 | ADDENBROOKES CLIN INVEST | Address | 1 | 10% | 2% | 10 |
7 | ADDENBROOKES CLIN INVESTIGAT | Address | 1 | 40% | 0% | 2 |
8 | BASICMED SCI | Address | 1 | 50% | 0% | 1 |
9 | C5B 9 TERMINAL COMPLEX | Author keyword | 1 | 50% | 0% | 1 |
10 | CARDIOVAC | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLC OXLDL | 1 | 100% | 0% | 2 | Search GLC+OXLDL | Search GLC+OXLDL |
2 | C5B 9 TERMINAL COMPLEX | 1 | 50% | 0% | 1 | Search C5B+9+TERMINAL+COMPLEX | Search C5B+9+TERMINAL+COMPLEX |
3 | CASPASE BCL 2 | 1 | 50% | 0% | 1 | Search CASPASE+BCL+2 | Search CASPASE+BCL+2 |
4 | CORONARY ARTERIAL MYOCYTE | 1 | 50% | 0% | 1 | Search CORONARY+ARTERIAL+MYOCYTE | Search CORONARY+ARTERIAL+MYOCYTE |
5 | LIGHT LDL | 1 | 50% | 0% | 1 | Search LIGHT+LDL | Search LIGHT+LDL |
6 | LOOH | 1 | 50% | 0% | 1 | Search LOOH | Search LOOH |
7 | MACROPHAGES HUMAN | 1 | 50% | 0% | 1 | Search MACROPHAGES+HUMAN | Search MACROPHAGES+HUMAN |
8 | P53 APOPTOSIS | 1 | 50% | 0% | 1 | Search P53+APOPTOSIS | Search P53+APOPTOSIS |
9 | REMOTE CELL DEATH | 1 | 50% | 0% | 1 | Search REMOTE+CELL+DEATH | Search REMOTE+CELL+DEATH |
10 | ALPHAMBETA2 INTEGRIN | 0 | 33% | 0% | 1 | Search ALPHAMBETA2+INTEGRIN | Search ALPHAMBETA2+INTEGRIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OXLDL INDUCED APOPTOSIS | 6 | 100% | 1% | 4 |
2 | LIPID CORE | 3 | 26% | 2% | 9 |
3 | MACROPHAGE AUTOPHAGY | 3 | 60% | 1% | 3 |
4 | ENHANCED ATHEROSCLEROSIS | 1 | 38% | 1% | 3 |
5 | SELECTIVE CLEARANCE | 1 | 38% | 1% | 3 |
6 | TREATED LIPOPROTEINS | 1 | 40% | 0% | 2 |
7 | ATHERECTOMY TISSUE | 1 | 33% | 0% | 2 |
8 | ATHEROSCLEROTIC RABBIT MODEL | 1 | 33% | 0% | 2 |
9 | INHIBITS MACROPHAGE APOPTOSIS | 1 | 33% | 0% | 2 |
10 | PLAQUE NECROSIS | 1 | 33% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Apoptotic cell death in atherosclerosis | 2003 | 115 | 51 | 37% |
Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis - The importance of lesion stage and phagocytic efficiency | 2005 | 314 | 100 | 20% |
Progression of atheroma - A struggle between death and procreation | 2002 | 166 | 122 | 32% |
Role of apoptosis in atherosclerosis and its therapeutic implications | 2004 | 113 | 142 | 30% |
Autophagy in Vascular Disease | 2015 | 3 | 118 | 18% |
Apoptosis in atherosclerosis: beneficial or detrimental? | 2000 | 174 | 86 | 37% |
The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability | 2006 | 53 | 30 | 43% |
Apoptosis in the atherosclerotic plaque - Quantitative and qualitative aspects | 1998 | 163 | 40 | 58% |
Vascular cell apoptosis in remodeling, restenosis, and plaque rupture | 2000 | 123 | 65 | 46% |
Oxidized low-density lipoprotein-induced apoptosis | 2002 | 196 | 116 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL VASC CELL BIOL | 1 | 100% | 0.4% | 2 |
2 | PATHOL AZ MIDDELHEIM | 1 | 100% | 0.4% | 2 |
3 | RICHARD B LYNNE V CHENEY CARDIOVASC | 1 | 100% | 0.4% | 2 |
4 | UNIT CARDIOVASC MED | 1 | 15% | 1.5% | 8 |
5 | ADDENBROOKES CLIN INVEST | 1 | 10% | 1.9% | 10 |
6 | ADDENBROOKES CLIN INVESTIGAT | 1 | 40% | 0.4% | 2 |
7 | BASICMED SCI | 1 | 50% | 0.2% | 1 |
8 | CARDIOVAC | 1 | 50% | 0.2% | 1 |
9 | CATHARINE BIRCH MCCORMICK GENOM | 1 | 50% | 0.2% | 1 |
10 | ELE ON MICROSCOPY A SAITA | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000129736 | LOX 1//LECTIN LIKE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1//LOX 1 RECEPTOR |
2 | 0.0000128106 | ARTERIOSCLEROTIC PLAQUE//BANK MONTREAL//BENZOAPYRENE DIONE |
3 | 0.0000115687 | HEMAGGLUTINATING VIRUS OF JAPAN//GAX//HVJ LIPOSOME |
4 | 0.0000113068 | APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN//CARDIAC OUTPUT INDEX//EXP CARDIOL |
5 | 0.0000106766 | VASCULAR DENDRITIC CELLS//MOL MED CEMM//OPPENHEIMER ATHEROSCLEROSIS |
6 | 0.0000100690 | VASC PHYSIOPATHOL//MEDIA LAYER//CORONARY ATHEROSCLEROTIC HEART DISEASE |
7 | 0.0000099295 | CELLULAR REPRESSOR OF E1A STIMULATED GENES//CREG//CELLULAR REPRESSOR OF E1A STIMULATED GENES CREG |
8 | 0.0000092005 | RAT AORTIC SMOOTH MUSCLE CELL//CINNAMOMUM CASSIA BARK//CLITOCYBIN A |
9 | 0.0000087439 | OXIDIZED LDL//LOW DENSITY LIPOPROTEIN//LIPOPROTEIN OXIDATION |
10 | 0.0000081323 | CHOLESTEROL OXIDES//CHOLESTEROL OXIDATION PRODUCTS//7 KETOCHOLESTEROL |